| Withdrawn | Efficacy and Safety of LGX818 in Patients With Advanced or Metastatic BRAF V600 Mutant NSCLC Non-Small Cell Lung Cancer | Phase 2 | 2015-06-01 |
| Terminated | MEK162 in Healthy Subjects With Normal Hepatic Function and Subjects With Impaired Hepatic Function Hepatic Impairment | Phase 1 | 2014-03-01 |
| Terminated | A Phase Ib/II Study of AEB071 and MEK162 in Adult Patients With Metastatic Uveal Melanoma Uveal Melanoma | Phase 1 / Phase 2 | 2013-08-01 |
| Completed | A Study of MEK162 and Paclitaxel in Patients With Epithelial Ovarian, Fallopian Tube or Peritoneal Cancer Epithelial Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer | Phase 1 | 2012-07-01 |
| Withdrawn | Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of MEK162 in Noonan Syndrome Hypertrophic Cardiomy Cardiomegaly | Phase 2 | 2012-02-01 |
| Completed | A Study of ARRY-614 in Patients With Low or Intermediate-1 Risk Myelodysplastic Syndromes Myelodysplastic Syndromes | Phase 1 | 2012-01-01 |
| Completed | A Phase I Study of Oral MEK162 in Japanese Patients With Advanced Solid Tumors Advanced Solid Tumor | Phase 1 | 2011-11-01 |
| Completed | Safety, Pharmacokinetics and Pharmacodynamics of BKM120 Plus MEK162 in Selected Advanced Solid Tumor Patients Advanced Solid Tumors, Selected Solid Tumors | Phase 1 | 2011-08-01 |
| Completed | MEK162 and RAF265 in Adult Patients With Advanced Solid Tumors Harboring RAS or BRAFV600E Mutations Advanced Solid Tumors | Phase 1 | 2011-06-01 |
| Completed | A Safety Study of ARRY-502 in Healthy Subjects Healthy | Phase 1 | 2011-05-01 |
| Completed | A Study of ARRY-382 in Patients With Selected Advanced or Metastatic Cancers Metastatic Cancer | Phase 1 | 2011-03-01 |
| Completed | A Study of ARRY-520 and Bortezomib Plus Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma Multiple Myeloma, Plasma Cell Leukemia | Phase 1 | 2010-12-01 |
| Completed | A Safety Study of ARRY-403 in Patients With Type 2 Diabetes Type 2 Diabetes | Phase 1 | 2009-08-01 |
| Completed | A Study of ARRY-438162 (MEK162) in Patients With Advanced Cancer Advanced Solid Tumors, Advanced or Metastatic Biliary Cancer, Metastatic Colorectal Cancer | Phase 1 | 2009-08-01 |
| Completed | A Study of ARRY-614 in Patients With Low or Intermediate-1 Risk Myelodysplastic Syndrome Myelodysplastic Syndromes | Phase 1 | 2009-06-01 |
| Completed | A Safety Study of ARRY-300 in Healthy Subjects Healthy | Phase 1 | 2009-01-01 |
| Completed | A Study of ARRY-334543 and Docetaxel in Patients With Advanced Cancer Advanced Cancer | Phase 1 | 2009-01-01 |
| Completed | A Safety Study of ARRY-371797 in Healthy Subjects Healthy | Phase 1 | 2008-10-31 |
| Completed | A Study of ARRY-371797 in Patients With Rheumatoid Arthritis Rheumatoid Arthritis | Phase 1 | 2008-07-01 |
| Completed | A Study of ARRY-334543 and Capecitabine in Patients With Advanced Cancer Advanced Cancer | Phase 1 | 2008-06-01 |
| Completed | A Study of ARRY-438162 in Patients With Rheumatoid Arthritis Rheumatoid Arthritis | Phase 2 | 2008-03-01 |
| Completed | A Study of ARRY-334543 in Patients With Advanced Cancer Advanced Cancer | Phase 1 | 2008-02-01 |
| Completed | A Study of ARRY-520 in Patients With Advanced Cancer Advanced Solid Tumors | Phase 1 | 2007-04-01 |
| Completed | A Study of ARRY-334543 in Patients With Advanced Cancer Advanced Cancer | Phase 1 | 2006-01-01 |
| Completed | A Study of ARRY-142886 in Patients With Advanced Cancer Advanced Cancer | Phase 1 | 2004-06-01 |